MORGAN STANLEY - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$3,010,182
-22.3%
716,710
+11.2%
0.00%
Q4 2022$3,875,193
-8.3%
644,791
-11.2%
0.00%
-100.0%
Q3 2022$4,225,000
-18.8%
726,105
-16.6%
0.00%0.0%
Q2 2022$5,200,000
+1438.5%
871,096
+1105.7%
0.00%
Q1 2022$338,000
+36.8%
72,251
-27.4%
0.00%
Q4 2021$247,000
-84.9%
99,540
-82.1%
0.00%
Q3 2021$1,641,000
-38.4%
556,477
-47.8%
0.00%
Q2 2021$2,664,000
-37.6%
1,065,781
-27.4%
0.00%
-100.0%
Q1 2021$4,272,000
+250.2%
1,467,994
+287.6%
0.00%
Q4 2020$1,220,000
+13455.6%
378,780
+8793.6%
0.00%
Q3 2020$9,000
+350.0%
4,259
+120.8%
0.00%
Q2 2020$2,000
-50.0%
1,929
-56.1%
0.00%
Q1 2020$4,000
-84.6%
4,398
-73.5%
0.00%
Q4 2019$26,000
+100.0%
16,568
+3.7%
0.00%
Q3 2019$13,000
+116.7%
15,981
+129.9%
0.00%
Q2 2019$6,000
-70.0%
6,951
-66.0%
0.00%
Q1 2019$20,000
-80.2%
20,427
-85.2%
0.00%
Q4 2018$101,000
-46.8%
137,748
+56.0%
0.00%
Q3 2018$190,000
-66.4%
88,299
-22.1%
0.00%
Q2 2018$565,000
+107.0%
113,365
+62.0%
0.00%
Q1 2018$273,000
+170.3%
69,974
+86.5%
0.00%
Q4 2017$101,000
-32.7%
37,516
-20.4%
0.00%
Q3 2017$150,000
+18.1%
47,115
+23.4%
0.00%
Q2 2017$127,000
-73.9%
38,179
-66.9%
0.00%
Q1 2017$486,000115,4140.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders